SQUAMOUS CELL CARCINOMA ANTIGEN INCREASED

This adverse event was reported 14 times

These drugs are most commonly taken by patients reporting SQUAMOUS CELL CARCINOMA ANTIGEN INCREASED:

# Drug Count
0 PEMBROLIZUMAB 4
1 CEMIPLIMAB-RWLC 2
2 PACLITAXEL 2
3 PACLITAXEL (AIBUMIN-BOUND) 2
4 AMIKACIN SULFATE 1
5 CARBIDOPA AND LEVODOPA 1
6 CARBOPLATIN 1
7 CISPLATIN 1
8 FILGRASTIM 1
9 GEFITINIB 1
See all common drugs associated with SQUAMOUS CELL CARCINOMA ANTIGEN INCREASED

SQUAMOUS CELL CARCINOMA ANTIGEN INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEMIPLIMAB-RWLC 2 0.0010
1 AMIKACIN SULFATE 1 0.0006
2 IVERMECTIN 1 0.0002
3 TIGECYCLINE 1 0.0002
4 RAMUCIRUMAB 1 0.0002
5 GEFITINIB 1 0.0001
6 ITRACONAZOLE 1 0.0001
7 PEMBROLIZUMAB 4 0.0000
8 IXEKIZUMAB 1 0.0000
9 FILGRASTIM 1 0.0000
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA ANTIGEN INCREASED